Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Royal Oak, MI
NPI: 1114987047Primary Practice Location
BEAUMONT HOSPITAL ROYAL OAK
3601 W 13 Mile Rd, Royal Oak, MI
Primary Employer
Michigan Healthcare Professionals PC
mhpdoctor.com
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 336 | 875 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 319 | 840 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 295 | 681 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 217 | 385 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 146 | 437 |
Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?
Authors: Adewale Fawole, Susanna Gaikazian, Seerin Shatavi, Rafat Abonour
Publication Date: 2014-03-25
When leucocytosis is not leukaemia.
Authors: Nwabundo Anusim, Filip Ionescu
Journal: Am Fam Physician
Inferior Vena Cava Filter Retrieval Trends: A Single-Center Experience.
Authors: Nwabundo Anusim, Filip Ionescu, Leann Blankenship, Eva Ma
Journal: TH Open
Publication Date: 2021-02-10
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, DRUG: Pembrolizumab, DRUG: Gemcitabine, DRUG: Pemetrexed Disodium, DRUG: Erlotinib Hydrochloride, RADIATION: Stereotactic Body Radiation Therapy (SBRT), RADIATION: Intensity-Modulated Radiation Therapy (IMRT), RADIATION: 3-Dimensional Conformal Radiation Therapy (3D-CRT)
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Tremelimumab, BIOLOGICAL: Durvalumab
Lead Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DIAGNOSTIC_TEST: Cardiac MRI
